Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for VCYT

Stock NameVeracyte Inc
TickerVCYT(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS92337F1075
LEI529900ESWZRHXOW27Z37

Show aggregate VCYT holdings

News associated with VCYT

1,616 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by Headlands Technologies LLC
Headlands Technologies LLC purchased a new position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,616 shares of the biotechnology company’s stock, valued at approximately $48,000. Several other large investors have also […] - 2025-08-13 05:22:59
Veracyte, Inc. (NASDAQ:VCYT) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have earned a consensus rating of “Moderate Buy” from the ten research firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and eight have issued a buy rating on […] - 2025-08-12 02:44:59
Veracyte, Inc. (NASDAQ:VCYT) Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank
Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 12.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,368 shares of the biotechnology company’s stock after purchasing an additional 3,201 shares during the […] - 2025-08-06 04:52:59
Veracyte (NASDAQ:VCYT) Stock Acquired Rep. Gilbert Ray Cisneros, Jr.
Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Veracyte, Inc. (NASDAQ:VCYT). In a filing disclosed on July 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in Veracyte stock on June 16th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account. Representative Gilbert Ray […] - 2025-07-28 03:00:42
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Bank Julius Baer & Co. Ltd Zurich
Bank Julius Baer & Co. Ltd Zurich reduced its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 9.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 18,905 shares of the biotechnology company’s stock after selling 2,059 shares during the period. […] - 2025-07-25 06:31:01
Brokerages Set Veracyte, Inc. (NASDAQ:VCYT) Price Target at $40.90
Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eight have assigned a buy rating to […] - 2025-07-21 02:14:56
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Teacher Retirement System of Texas
Teacher Retirement System of Texas lowered its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 49.3% during the first quarter, HoldingsChannel reports. The institutional investor owned 33,938 shares of the biotechnology company’s stock after selling 33,036 shares during the quarter. Teacher Retirement System of Texas’ holdings in Veracyte were worth $1,006,000 at the end […] - 2025-07-14 04:50:48
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Diversified Trust Co
Diversified Trust Co lowered its stake in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 48.1% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,840 shares of the biotechnology company’s stock after selling 8,209 shares during the quarter. Diversified Trust Co’s holdings […] - 2025-07-02 05:18:56
Veracyte, Inc. (NASDAQ:VCYT) Receives $40.90 Average Target Price from Analysts
Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the ten analysts that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and eight have assigned a buy recommendation to the […] - 2025-06-26 02:23:05
Exchange Traded Concepts LLC Increases Stake in Veracyte, Inc. (NASDAQ:VCYT)
Exchange Traded Concepts LLC boosted its holdings in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 32.5% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 91,994 shares of the biotechnology company’s stock after buying an additional 22,565 shares during the period. Exchange Traded Concepts LLC owned approximately 0.12% […] - 2025-06-17 05:36:53
Rhumbline Advisers Sells 2,870 Shares of Veracyte, Inc. (NASDAQ:VCYT)
Rhumbline Advisers cut its holdings in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 2.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 120,454 shares of the biotechnology company’s stock after selling 2,870 shares during the period. Rhumbline Advisers’ holdings in Veracyte were worth $3,571,000 as […] - 2025-06-15 06:08:55
California State Teachers Retirement System Sells 510 Shares of Veracyte, Inc. (NASDAQ:VCYT)
California State Teachers Retirement System lowered its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 0.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 71,834 shares of the biotechnology company’s stock after selling 510 shares during the […] - 2025-06-06 06:02:58
Janus Henderson Group PLC Acquires 4,000 Shares of Veracyte, Inc. (NASDAQ:VCYT)
Janus Henderson Group PLC raised its holdings in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 13.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 34,326 shares of the biotechnology company’s stock after acquiring an additional 4,000 shares during the quarter. Janus Henderson […] - 2025-05-23 05:27:01
Deutsche Bank AG Purchases 24,197 Shares of Veracyte, Inc. (NASDAQ:VCYT)
Deutsche Bank AG grew its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 42.4% in the fourth quarter, Holdings Channel reports. The fund owned 81,266 shares of the biotechnology company’s stock after acquiring an additional 24,197 shares during the quarter. Deutsche Bank AG’s holdings in Veracyte were worth $3,218,000 at the end of the […] - 2025-05-21 04:42:57
The Manufacturers Life Insurance Company Sells 1,731 Shares of Veracyte, Inc. (NASDAQ:VCYT)
The Manufacturers Life Insurance Company lessened its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 4.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 40,186 shares of the biotechnology company’s stock after selling 1,731 shares during the quarter. The Manufacturers Life Insurance Company […] - 2025-05-12 04:43:01
Tudor Investment Corp ET AL Sells 20,531 Shares of Veracyte, Inc. (NASDAQ:VCYT)
Tudor Investment Corp ET AL lessened its holdings in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 50.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,342 shares of the biotechnology company’s stock after selling 20,531 shares during the quarter. […] - 2025-05-08 06:44:55
Veracyte, Inc. (NASDAQ:VCYT) Shares Bought by Hsbc Holdings PLC
Hsbc Holdings PLC grew its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 14.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,084 shares of the biotechnology company’s stock after acquiring an additional 1,406 shares during the quarter. Hsbc Holdings PLC’s holdings […] - 2025-05-08 06:07:00
Price T Rowe Associates Inc. MD Has $1.92 Million Holdings in Veracyte, Inc. (NASDAQ:VCYT)
Price T Rowe Associates Inc. MD raised its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 3.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 48,414 shares of the biotechnology company’s stock after acquiring an additional 1,816 shares during the quarter. […] - 2025-05-08 04:58:52
Voya Investment Management LLC Decreases Position in Veracyte, Inc. (NASDAQ:VCYT)
Voya Investment Management LLC decreased its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 7.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,066 shares of the biotechnology company’s stock after selling 1,781 shares during the period. Voya Investment Management […] - 2025-05-07 05:58:57
Brokerages Set Veracyte, Inc. (NASDAQ:VCYT) PT at $42.60
Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the ten ratings firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and eight have assigned a buy recommendation to the […] - 2025-05-07 02:19:08
Veracyte, Inc. (NASDAQ:VCYT) Short Interest Up 22.5% in April
Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 5,110,000 shares, a growth of 22.5% from the March 31st total of 4,170,000 shares. Based on an average daily volume of 956,000 shares, the short-interest ratio is […] - 2025-05-05 02:36:53
First Trust Advisors LP Has $8.08 Million Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)
First Trust Advisors LP boosted its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 155.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 204,042 shares of the biotechnology company’s stock after acquiring an additional 124,275 shares during the quarter. First Trust Advisors […] - 2025-04-30 05:52:59
Russell Investments Group Ltd. Has $2.60 Million Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)
Russell Investments Group Ltd. increased its position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 233.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 65,541 shares of the biotechnology company’s stock after purchasing an additional 45,876 shares during the quarter. […] - 2025-04-18 04:53:09
Veracyte, Inc. (NASDAQ:VCYT) Shares Bought by Alliancebernstein L.P.
Alliancebernstein L.P. grew its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 2.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 98,420 shares of the biotechnology company’s stock after purchasing an additional 2,000 shares during the period. Alliancebernstein L.P. owned […] - 2025-04-15 04:52:54
Veracyte (NASDAQ:VCYT) Given New $37.00 Price Target at Guggenheim
Veracyte (NASDAQ:VCYT – Get Free Report) had its price objective cut by stock analysts at Guggenheim from $45.00 to $37.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Guggenheim’s price objective points to a potential upside of 22.31% from the stock’s current price. […] - 2025-04-11 04:46:55
Veracyte (NASDAQ:VCYT) Shares Gap Down After Analyst Downgrade
Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) gapped down before the market opened on Wednesday after Guggenheim lowered their price target on the stock from $45.00 to $37.00. The stock had previously closed at $28.88, but opened at $27.22. Guggenheim currently has a buy rating on the stock. Veracyte shares last traded at […] - 2025-04-10 02:40:48
Norges Bank Takes $8.93 Million Position in Veracyte, Inc. (NASDAQ:VCYT)
Norges Bank acquired a new position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) in the fourth quarter, Holdings Channel reports. The firm acquired 225,602 shares of the biotechnology company’s stock, valued at approximately $8,934,000. A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in VCYT. […] - 2025-04-09 04:56:52
Veracyte, Inc. (NASDAQ:VCYT) Shares Acquired by Vanguard Group Inc.
Vanguard Group Inc. increased its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 6.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 8,211,612 shares of the biotechnology company’s stock after buying an additional 463,098 shares during the quarter. Vanguard Group Inc. owned about 0.11% of Veracyte worth $325,180,000 as of its most […] - 2025-04-04 05:04:58
Corebridge Financial Inc. Lowers Stake in Veracyte, Inc. (NASDAQ:VCYT)
Corebridge Financial Inc. decreased its position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 7.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 38,204 shares of the biotechnology company’s stock after selling 2,885 shares during the quarter. Corebridge Financial Inc.’s holdings in Veracyte were worth $1,513,000 at the end of the […] - 2025-04-03 05:49:01
Prudential Financial Inc. Has $4.83 Million Stake in Veracyte, Inc. (NASDAQ:VCYT)
Prudential Financial Inc. raised its position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 602.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 122,003 shares of the biotechnology company’s stock after acquiring an additional 104,639 shares during the period. […] - 2025-04-01 05:32:46

iShares Healthcare Innovation UCITS ETF USD (Acc) VCYT holdings

DateNumber of VCYT Shares HeldBase Market Value of VCYT SharesLocal Market Value of VCYT SharesChange in VCYT Shares HeldChange in VCYT Base ValueCurrent Price per VCYT Share HeldPrevious Price per VCYT Share Held
2025-11-12 (Wednesday)90,460USD 3,826,458USD 3,826,458
2025-11-11 (Tuesday)90,460USD 3,859,024VCYT holding increased by 28043USD 3,859,0240USD 28,043 USD 42.66 USD 42.35
2025-11-10 (Monday)90,460USD 3,830,981VCYT holding increased by 58799USD 3,830,9810USD 58,799 USD 42.35 USD 41.7
2025-11-07 (Friday)90,460USD 3,772,182VCYT holding increased by 905USD 3,772,1820USD 905 USD 41.7 USD 41.69
2025-11-06 (Thursday)90,460USD 3,771,277VCYT holding decreased by -393501USD 3,771,2770USD -393,501 USD 41.69 USD 46.04
2025-11-05 (Wednesday)90,460USD 4,164,778VCYT holding increased by 897363USD 4,164,7780USD 897,363 USD 46.04 USD 36.12
2025-11-04 (Tuesday)90,460USD 3,267,415VCYT holding decreased by -29852USD 3,267,4150USD -29,852 USD 36.12 USD 36.45
2025-11-03 (Monday)90,460USD 3,297,267VCYT holding increased by 33470USD 3,297,2670USD 33,470 USD 36.45 USD 36.08
2025-10-31 (Friday)90,460USD 3,263,797VCYT holding increased by 67845USD 3,263,7970USD 67,845 USD 36.08 USD 35.33
2025-10-30 (Thursday)90,460USD 3,195,952VCYT holding decreased by -7237USD 3,195,9520USD -7,237 USD 35.33 USD 35.41
2025-10-29 (Wednesday)90,460USD 3,203,189VCYT holding decreased by -17187USD 3,203,1890USD -17,187 USD 35.41 USD 35.6
2025-10-28 (Tuesday)90,460USD 3,220,376VCYT holding decreased by -33470USD 3,220,3760USD -33,470 USD 35.6 USD 35.97
2025-10-27 (Monday)90,460USD 3,253,846VCYT holding decreased by -68750USD 3,253,8460USD -68,750 USD 35.97 USD 36.73
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VCYT by Blackrock for IE00BYZK4776

Show aggregate share trades of VCYT

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-24SELL-76836.73036.845 36.834USD -28,288 33.34 Loss of -2,684 on sale
2025-09-11BUY38531.86032.335 32.287USD 12,431 33.19
2025-07-08SELL-38426.58026.780 26.760USD -10,276 33.76 Profit of 2,688 on sale
2025-06-24SELL-37526.88027.210 27.177USD -10,191 34.19 Profit of 2,631 on sale
2025-06-23BUY2,34126.71026.730 26.728USD 62,570 34.25
2025-06-11SELL-37427.93028.430 28.380USD -10,614 34.71 Profit of 2,366 on sale
2025-05-30SELL-37426.61027.540 27.447USD -10,265 35.20 Profit of 2,899 on sale
2025-05-21BUY37427.61028.790 28.672USD 10,723 35.68
2025-05-14SELL-2,23828.49029.760 29.633USD -66,319 35.93 Profit of 14,100 on sale
2025-04-30SELL-37330.50031.375 31.288USD -11,670 36.48 Profit of 1,936 on sale
2025-04-28SELL-37331.67032.850 32.732USD -12,209 36.58 Profit of 1,435 on sale
2025-04-25SELL-37332.23032.360 32.347USD -12,065 36.62 Profit of 1,595 on sale
2025-04-11SELL-2,19631.80031.800 31.800USD -69,833 37.08 Profit of 11,588 on sale
2025-04-08SELL-1,09828.88030.970 30.761USD -33,776 37.30 Profit of 7,181 on sale
2025-04-07SELL-76829.53030.800 30.673USD -23,557 37.39 Profit of 5,160 on sale
2025-03-31SELL-73229.65030.160 30.109USD -22,040 37.77 Profit of 5,610 on sale
2025-03-21SELL-73031.82032.050 32.027USD -23,380 38.24 Profit of 4,537 on sale
2025-03-12SELL-36730.96032.340 32.202USD -11,818 38.95 Profit of 2,476 on sale
2025-02-28SELL-36734.76035.160 35.120USD -12,889 39.77 Profit of 1,707 on sale
2025-02-25BUY36733.46038.785 38.252USD 14,039 40.05
2025-02-20SELL-36741.05042.210 42.094USD -15,448 40.07 Loss of -744 on sale
2025-02-19BUY73242.11042.260 42.245USD 30,923 40.03
2025-02-18BUY36640.42042.340 42.148USD 15,426 40.02
2024-12-30SELL-72040.00040.447 40.402USD -29,090 38.36 Loss of -1,469 on sale
2024-12-06SELL-36444.13046.000 45.813USD -16,676 37.87 Loss of -2,892 on sale
2024-12-04SELL-36444.09044.500 44.459USD -16,183 37.47 Loss of -2,544 on sale
2024-12-03SELL-72843.66043.770 43.759USD -31,857 37.24 Loss of -4,746 on sale
2024-11-21SELL-36638.94039.810 39.723USD -14,539 35.27 Loss of -1,629 on sale
2024-11-20SELL-37139.20039.800 39.740USD -14,744 35.05 Loss of -1,739 on sale
2024-11-19SELL-37139.15039.190 39.186USD -14,538 34.81 Loss of -1,623 on sale
2024-11-18SELL-1,46036.71037.300 37.241USD -54,372 34.69 Loss of -3,720 on sale
2024-11-12SELL-36438.24038.780 38.726USD -14,096 34.46 Loss of -1,554 on sale
2024-11-07SELL-36437.34041.430 41.021USD -14,932 34.08 Loss of -2,527 on sale
2024-11-05SELL-72835.93036.260 36.227USD -26,373 33.68 Loss of -1,852 on sale
2024-10-28SELL-36534.12034.360 34.336USD -12,533 32.80 Loss of -562 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VCYT

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19402,884350744,51854.1%
2025-09-18133,6940302,24644.2%
2025-09-17102,785125273,62537.6%
2025-09-1687,0400147,74558.9%
2025-09-15132,51756260,10150.9%
2025-09-12104,5280208,62550.1%
2025-09-11145,4620339,20642.9%
2025-09-10375,7030425,98488.2%
2025-09-09166,0260264,89862.7%
2025-09-08308,5880416,29974.1%
2025-09-05304,50710,500433,10670.3%
2025-09-04285,1989,691351,70781.1%
2025-09-03290,7740410,27570.9%
2025-09-02242,677328272,94788.9%
2025-08-29221,15998280,82078.8%
2025-08-28175,0742379,19446.2%
2025-08-27232,9790412,23756.5%
2025-08-26109,7630254,60343.1%
2025-08-25126,935150195,39565.0%
2025-08-22178,0730354,77350.2%
2025-08-21181,7268,870254,59671.4%
2025-08-20138,840313198,82969.8%
2025-08-19153,214124248,80361.6%
2025-08-18106,9062,453169,68863.0%
2025-08-15178,9203,513228,77478.2%
2025-08-14322,958483432,34174.7%
2025-08-13669,26626854,66578.3%
2025-08-12356,389699440,94580.8%
2025-08-11355,148650511,01069.5%
2025-08-08457,220700602,61375.9%
2025-08-07583,5761201,202,65148.5%
2025-08-06313,07396542,79657.7%
2025-08-05399,68716494,59280.8%
2025-08-04291,020107420,20969.3%
2025-08-01239,65310322,44674.3%
2025-07-31311,9163,467452,66568.9%
2025-07-30406,4081,200573,80070.8%
2025-07-29514,19414682,09875.4%
2025-07-281,469,0601602,707,10054.3%
2025-07-25980,57416,8282,309,75842.5%
2025-07-2470,902139182,75938.8%
2025-07-23114,868377213,73553.7%
2025-07-22131,718134372,35135.4%
2025-07-2194,2783,694206,20745.7%
2025-07-18151,3241,062447,37733.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.